Status:
UNKNOWN
A Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases.
Lead Sponsor:
Carmel Medical Center
Conditions:
Myeloproliferative Disease
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Pulmonary hypertension (PH) is defined as a group of diseases characterised by an elevated mean pulmonary artery pressure (Ppa) ≥25 mmHg at rest. Recently, chronic myeloproliferative diseases (CMPD) a...
Detailed Description
study will include the following: * sex * age * BMI * ethnicity * age diagnosed with Myeloproliferative disease * clinical manifestations of the myeloproliferative disease * JAK2 mutation * known hem...
Eligibility Criteria
Inclusion
- 1\) consenting patients diagnosed with a myeloproliferative disease
Exclusion
- 1\) Refusal to have an echocardiogram or answer the St. George respiratory questionnaire
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01884974
Start Date
July 1 2013
Last Update
June 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pulmonology Institute, Carmel Medical Center
Haifa, Israel, 34632